Longboard Pharmaceuticals Competitors and Similar CompaniesClear all
Longboard Pharmaceuticals's competitors and similar companies include Aurealis Therapeutics and ADMA Biologics.
 Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. |  Aurealis Therapeutics Aurealis Therapeutics (formerly known as Aurealis Pharma) is a biopharmaceutical company developing medicines for the treatment of cancer and chronic wounds. |  ADMA Biologics ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases. | |
Founding Date | Founding Date 2020 | Founding Date 2010 | Founding Date 2004 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ San Diego, US | Locations Basel, CH HQ Kuopio, FI | Locations Ramsey, US HQ Boca Raton, US |
Employees | Employees 5056% increase | Employees 18 | Employees 313 |
Valuation ($) | Valuation ($) 2.3 b | Valuation ($) N/A | Valuation ($) 3.9 b |
Financial | |||
Net income | Net income ($54.4m) (FY, 2023) | Net income N/A | Net income $146.9m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 5.7m | Total funding raised $ 20m |
For sources of this data, please see the company profile
View Company Profiles
Aurealis Therapeutics
HQ
Basel, CH
Employees
18
Aurealis Therapeutics (formerly known as Aurealis Pharma) is a biopharmaceutical company developing medicines for the treatment of cancer and chronic wounds.
View companyADMA Biologics
HQ
Ramsey, US
Employees
313
ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases.
View company